• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Self-reported functional impairment and frailty improve the prediction of healthcare expenditures

byAndrew LeeandKiera Liblik
April 17, 2023
in Chronic Disease, Public Health
Reading Time: 2 mins read
Increased risk of stillbirth recurrence after a previous stillbirth
Share on FacebookShare on Twitter

1. In this retrospective cohort study, the inclusion of functional impairment and phenotypic frailty more accurately predicted healthcare costs in Medicare patients than claims-based indicators alone.

2. A greater number of self-reported functional impairments were associated with more significant incremental costs compared to those without functional impairments.

Evidence Rating Level: 3 (Average)

Study Rundown: Older adults account for a disproportionate amount of healthcare expenditure. Existing predictive models of healthcare costs are composed of claims-based indicators of the number of complex chronic medical conditions, which may fail to account for differences in patient characteristics. In this retrospective study of Medicare fee-for-service patients, 49.1% of women and 31.9% of men reported at least one functional impairment, and 34.3% of women and 19.1% of men met the phenotypic definition of frailty. Individuals with more significant functional impairment or greater frailty had higher Centers for Medicare & Medicaid Services Hierarchical Condition Category (CMS-HCC) scores, a greater burden of chronic medical conditions, higher claims-based frailty index, and higher subsequent health care costs during the 36-month follow-up period. Adding functional impairments or the frailty phenotype to the claims-based models predicted additional costs not captured by claims-derived measures alone. This study is limited in generalizability as the patients examined were all community-dwelling patients that may represent a potentially higher functioning group at baseline and may not capture all of the associated costs of older patients living precariously or in institutions with high levels of support.

Click to read the study in AIM

Relevant Reading: Concentration of potentially preventable spending among high-cost medicare subpopulations

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

A landmark court ruling was associated with increased travel across state borders for abortion care

In-Depth [retrospective cohort]: This retrospective cohort study examined whether self-reported functional impairments and phenotypic frailty were associated with increased healthcare costs after accounting for claims-based multimorbidity measures. Community-dwelling older adults underwent an index examination assessment of self-reported functional status and frailty phenotype. All participants were enrolled in Medicare fee-for-service programs from 12 months before the index examination until 36 months after. A total cohort of 4,318 women and 3,847 men were included in the analyses. Mean unadjusted costs were higher among individuals with versus without functional impairment. For women and men with three or four functional impairments, the costs were $26,142 and $32,964, respectively. For women and men without functional impairments, the costs were $8,408 and $10,427, respectively. The average marginal cost increase in women was $5,825 (95% Confidence Interval [CI], $4,585 to $7,066) per one standard deviation (SD) increment in the log-transformed CMS-HCC score. The average incremental costs for women with versus without functional impairments ranged from $2,632 to $6,065. Similarly, the average incremental costs for men with versus without functional impairment ranged from $2,093 to $9,627. The estimated total costs after adjustment for claims-based indicators varied by the number of functional impairments and frailty categories. The total cost for robust women without impairment was $8,124, and for robust men without impairment was $11,831. In summary, models that included functional impairments and the frailty phenotype resulted in more accurate cost prediction with an improvement and variability in cost.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasefrailtygeriatricgeriatric medicinehealthcare expenditurehealthcare expendituresmedicarepredicting healthcare expenditurespublic health
Previous Post

CAR-T Cell Therapy for Relapsed or Refractory High-Risk Neuroblastoma

Next Post

Early monoclonal antibody treatment associated with a reduced risk of COVID-19 hospitalization

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Natural language processing may automate data extraction from radiologic reports
Chronic Disease

Many patients using patient portals may not fully understand results of laboratory testing

August 26, 2026
Next Post
Mortality after trauma increasingly due to preexisting conditions

Early monoclonal antibody treatment associated with a reduced risk of COVID-19 hospitalization

Elective colectomy associated with improved survival in ulcerative colitis

Etrasimod improves clinical remission rates in patients with moderate-severe ulcerative colitis

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Prior BCG vaccination may be protective against severe COVID

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.